Your browser is no longer supported. Please, upgrade your browser.
GH Guardant Health, Inc. daily Stock Chart
Guardant Health, Inc.
Index- P/E- EPS (ttm)-2.80 Insider Own5.50% Shs Outstand85.34M Perf Week23.28%
Market Cap7.79B Forward P/E- EPS next Y-1.03 Insider Trans- Shs Float75.56M Perf Month78.64%
Income- PEG- EPS next Q-0.34 Inst Own84.00% Short Float3.44% Perf Quarter129.16%
Sales90.64M P/S85.90 EPS this Y-92.90% Inst Trans54.89% Short Ratio4.06 Perf Half Y-
Book/sh5.63 P/B16.21 EPS next Y26.40% ROA- Target Price68.00 Perf Year-
Cash/sh3.18 P/C28.69 EPS next 5Y35.40% ROE- 52W Range27.04 - 106.58 Perf YTD142.70%
Dividend- P/FCF- EPS past 5Y- ROI42.80% 52W High-14.40% Beta-
Dividend %- Quick Ratio9.00 Sales past 5Y- Gross Margin- 52W Low237.39% ATR6.91
Employees348 Current Ratio9.30 Sales Q/Q95.50% Oper. Margin- RSI (14)75.58 Volatility13.57% 9.16%
OptionableYes Debt/Eq- EPS Q/Q26.60% Profit Margin- Rel Volume2.06 Prev Close93.50
ShortableYes LT Debt/Eq- EarningsMar 18 AMC Payout- Avg Volume639.37K Price91.23
Recom1.80 SMA2034.41% SMA5076.14% SMA200109.77% Volume1,317,938 Change-2.43%
Feb-28-19Reiterated BofA/Merrill Neutral $42 → $60
Oct-29-18Initiated William Blair Outperform
Oct-29-18Initiated JP Morgan Overweight $42
Oct-29-18Initiated BofA/Merrill Neutral $37
Mar-19-19 07:48PM  Guardant Health Inc (GH) Files 10-K for the Fiscal Year Ended on December 31, 2018
Mar-16-19 04:30PM  3 More Stocks That Have More Than Doubled in 2019 Motley Fool
Mar-15-19 11:07PM  Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-14-19 04:16PM  This Recent Diagnostics IPO Is Having An Astronomical Run Here's Why Investor's Business Daily
02:42PM  Harry Boxers 4 stocks running on earnings MarketWatch
Mar-13-19 05:17PM  Vera Bradley and Guardant Health surge while Express falls Associated Press +27.64%
04:31PM  Why Oaktree Capital Group, Guardant Health, and Clean Energy Fuels Jumped Today Motley Fool
11:55AM  Guardant Health Posts Healthy Post-Earnings Gains
11:48AM  Guardant Health Is Growing Like Gangbusters Motley Fool
10:43AM  Why Guardant Health Is Roaring Higher Today Motley Fool
07:12AM  Dow Jones Futures: This Big-Cap Index Is Leading Now; Red-Hot IPO Tops Views Investor's Business Daily
Mar-12-19 06:14PM  Guardant Health: 4Q Earnings Snapshot Associated Press +10.75%
04:05PM  Guardant Health Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Outlook GlobeNewswire
07:16AM  Why Guardant Health Is the Best Healthcare Stock You've Never Heard Of Motley Fool
01:58AM  Guardant Health to Present at the 39th Annual Cowen Health Care Conference GlobeNewswire
01:33AM  Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019 GlobeNewswire
Mar-11-19 05:08PM  Here's Why Guardant Health Soared 65.2% in February Motley Fool +6.20%
Mar-04-19 05:00AM  Precision Oncology Gives Guardant Stock Room to Run MoneyShow
Feb-28-19 04:32PM  Why Monster Beverage, Horizon Pharma, and Guardant Health Jumped Today Motley Fool +19.71%
11:57AM  Why Guardant Health Stock Is Jumping Today Motley Fool
Feb-27-19 04:30PM  Guardant360 Performance Matches Standard-of-Care Tissue Testing in First-Line, Advanced Non-Small Cell Lung Cancer, NILE Study Shows, Meeting Primary Endpoint GlobeNewswire
Feb-23-19 06:31AM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Feb-21-19 05:02PM  Baron Funds' Top 5 Buys in the 4th Quarter
Feb-20-19 11:35AM  Hot Cancer Detection Stock Still Has Room to Run
Feb-14-19 04:05PM  Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference GlobeNewswire +13.49%
Jan-29-19 09:38AM  What's next for this slow-moving Peninsula biotech IPO? American City Business Journals
Jan-18-19 12:51PM  Do Institutions Own Guardant Health, Inc. (NASDAQ:GH) Shares? Simply Wall St.
Jan-07-19 07:00AM  Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers GlobeNewswire +5.36%
Dec-24-18 09:53AM  Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more American City Business Journals -5.30%
Dec-20-18 07:00PM  Guardant Health to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-13-18 12:15PM  Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi GlobeNewswire
Dec-03-18 03:31PM  The Probable Reason Guardant Health Is Soaring Today Motley Fool +28.58%
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
Nov-19-18 04:29PM  Guardant Health reports first earnings since IPO MarketWatch -9.74%
04:05PM  Guardant Health Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-13-18 04:03PM  Guardant Health To Report Third Quarter Financial Results on November 19, 2018 GlobeNewswire
Nov-01-18 02:51PM  Where SoftBanks Vision Fund is deploying its $100 billion Yahoo Finance
Oct-31-18 03:34PM  Strong IPO pace continued in October but some cracks are showing American City Business Journals
Oct-29-18 10:17AM  Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more American City Business Journals -6.86%
Oct-19-18 08:00AM  Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting PR Newswire -10.77%
Oct-16-18 08:00AM  Lung Cancer Study Published in JAMA Oncology Shows Guardant360 Outperforms Tissue Biopsy Alone in Identification of Targetable Mutations PR Newswire +13.04%
Oct-15-18 02:02PM  Unicorn births outpace IPOs in Bay Area: Here are the 24 new ones so far this year American City Business Journals
Oct-09-18 04:03PM  Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire +6.63%
Oct-05-18 08:00AM  Todays Research Reports on Stocks to Watch: Guardant Health and Vaxart ACCESSWIRE -9.32%
Oct-04-18 02:15PM  Nasdaq Welcomes Guardant Health, Inc. (Nasdaq: GH) to The Nasdaq Stock Market GlobeNewswire
11:01AM  Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early MarketWatch
10:55AM  Guardant Health's stock soars in public debut after IPO prices above expectations MarketWatch
09:02AM  Guardant Health IPO prices above expected range to value company at $1.6 billion MarketWatch
Oct-03-18 07:38PM  Guardant Health Announces Pricing of Initial Public Offering GlobeNewswire
Sep-30-18 09:41AM  IPO Outlook For The Week: Diagnostics, Data Miners And Freelance Facilitators Benzinga
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.